Aquestive Therapeutics, Inc. (AQST) › Total AssetsAquestive Therapeutics, Inc. (AQST) — Total AssetsAnnual figures by fiscal year, from SEC filings.2017: $43.12M2018: $86.85M2019: $78.48M2020: $62.88M2021: $61.99M2022: $57.07M2023: $57.42M2024: $101.42M2025: $160.43M$160.43M2017Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$160.43M+58.2%2024$101.42M+76.6%2023$57.42M+0.6%2022$57.07M-7.9%2021$61.99M-1.4%2020$62.88M-19.9%2019$78.48M-9.6%2018$86.85M+101.4%2017$43.12M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share